Form 8-K - Current report:
SEC Accession No. 0000950103-24-016242
Filing Date
2024-11-13
Accepted
2024-11-13 16:13:43
Documents
14
Period of Report
2024-11-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp220630_8k.htm   iXBRL 8-K 27751
2 EXHIBIT 3.1 dp220630_ex0301.htm EX-3.1 327818
  Complete submission text file 0000950103-24-016242.txt   581083

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adct-20241111.xsd EX-101.SCH 3036
4 XBRL LABEL FILE adct-20241111_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adct-20241111_pre.xml EX-101.PRE 22373
16 EXTRACTED XBRL INSTANCE DOCUMENT dp220630_8k_htm.xml XML 3765
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39071 | Film No.: 241454371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)